<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2020-10-07" version="226">
<accession>P40763</accession>
<accession>A8K7B8</accession>
<accession>K7ENL3</accession>
<accession>O14916</accession>
<accession>Q9BW54</accession>
<name>STAT3_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="58">Signal transducer and activator of transcription 3</fullName>
</recommendedName>
<alternativeName>
<fullName>Acute-phase response factor</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="58">STAT3</name>
<name type="synonym" evidence="58">APRF</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Cell" volume="77" first="63" last="71">
<title>Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.</title>
<authorList>
<person name="Akira S."/>
<person name="Nishio Y."/>
<person name="Inoue M."/>
<person name="Wang X.-J."/>
<person name="Wei S."/>
<person name="Matsusaka T."/>
<person name="Yoshida K."/>
<person name="Sudo T."/>
<person name="Naruto M."/>
<person name="Kishimoto T."/>
</authorList>
<dbReference type="PubMed" id="7512451"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90235-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT TYR-561</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="Gene" volume="213" first="119" last="124">
<title>Highly conserved amino-acid sequence between murine STAT3 and a revised human STAT3 sequence.</title>
<authorList>
<person name="Della Pietra L."/>
<person name="Bressan A."/>
<person name="Pezzotti A."/>
<person name="Serlupi-Crescenzi O."/>
</authorList>
<dbReference type="PubMed" id="9630560"/>
<dbReference type="DOI" id="10.1016/s0378-1119(98)00185-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="patent" date="2012-04-18" number="EP2440214">
<title>Methods for treating chronic kidney disease.</title>
<authorList>
<person name="Feinstein E."/>
<person name="Adamsky S."/>
<person name="Erlich S."/>
<person name="Molitoris B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2004-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ILE-143</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND DEL-701)</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="1997-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Della Pietra L."/>
<person name="Bressan A."/>
<person name="Pezzotti A.R."/>
<person name="Serlupi-Crescenzi O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 564-704</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="Science" volume="267" first="1990" last="1994">
<title>Requirement of serine phosphorylation for formation of STAT-promoter complexes.</title>
<authorList>
<person name="Zhang X."/>
<person name="Blenis J."/>
<person name="Li H.-C."/>
<person name="Schindler C."/>
<person name="Chen-Kiang S."/>
</authorList>
<dbReference type="PubMed" id="7701321"/>
<dbReference type="DOI" id="10.1126/science.7701321"/>
</citation>
<scope>PHOSPHORYLATION AT SERINE RESIDUES</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1997" name="Science" volume="278" first="1803" last="1805">
<title>Specific inhibition of Stat3 signal transduction by PIAS3.</title>
<authorList>
<person name="Chung C.D."/>
<person name="Liao J."/>
<person name="Liu B."/>
<person name="Rao X."/>
<person name="Jay P."/>
<person name="Berta P."/>
<person name="Shuai K."/>
</authorList>
<dbReference type="PubMed" id="9388184"/>
<dbReference type="DOI" id="10.1126/science.278.5344.1803"/>
</citation>
<scope>INTERACTION WITH PIAS3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="2043" last="2054">
<title>Etk, a Btk family tyrosine kinase, mediates cellular transformation by linking Src to STAT3 activation.</title>
<authorList>
<person name="Tsai Y.T."/>
<person name="Su Y.H."/>
<person name="Fang S.S."/>
<person name="Huang T.N."/>
<person name="Qiu Y."/>
<person name="Jou Y.S."/>
<person name="Shih H.M."/>
<person name="Kung H.J."/>
<person name="Chen R.H."/>
</authorList>
<dbReference type="PubMed" id="10688651"/>
<dbReference type="DOI" id="10.1128/mcb.20.6.2043-2054.2000"/>
</citation>
<scope>PHOSPHORYLATION BY BMX</scope>
<scope>INTERACTION WITH BMX</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="297" first="811" last="817">
<title>The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation.</title>
<authorList>
<person name="Yamamoto T."/>
<person name="Sekine Y."/>
<person name="Kashima K."/>
<person name="Kubota A."/>
<person name="Sato N."/>
<person name="Aoki N."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="12359225"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)02291-x"/>
</citation>
<scope>FUNCTION IN IL6 SIGNALING</scope>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="8004" last="8011">
<title>Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a.</title>
<authorList>
<person name="Giraud S."/>
<person name="Bienvenu F."/>
<person name="Avril S."/>
<person name="Gascan H."/>
<person name="Heery D.M."/>
<person name="Coqueret O."/>
</authorList>
<dbReference type="PubMed" id="11773079"/>
<dbReference type="DOI" id="10.1074/jbc.m111486200"/>
</citation>
<scope>INTERACTION WITH NCOA1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="J. Exp. Med." volume="196" first="641" last="653">
<title>Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation.</title>
<authorList>
<person name="Yoshida T."/>
<person name="Hanada T."/>
<person name="Tokuhisa T."/>
<person name="Kosai K."/>
<person name="Sata M."/>
<person name="Kohara M."/>
<person name="Yoshimura A."/>
</authorList>
<dbReference type="PubMed" id="12208879"/>
<dbReference type="DOI" id="10.1084/jem.20012127"/>
</citation>
<scope>INTERACTION WITH HCV CORE PROTEIN</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="J. Immunol." volume="168" first="5699" last="5708">
<title>A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R.</title>
<authorList>
<person name="Parham C."/>
<person name="Chirica M."/>
<person name="Timans J."/>
<person name="Vaisberg E."/>
<person name="Travis M."/>
<person name="Cheung J."/>
<person name="Pflanz S."/>
<person name="Zhang R."/>
<person name="Singh K.P."/>
<person name="Vega F."/>
<person name="To W."/>
<person name="Wagner J."/>
<person name="O'Farrell A.-M."/>
<person name="McClanahan T.K."/>
<person name="Zurawski S."/>
<person name="Hannum C."/>
<person name="Gorman D."/>
<person name="Rennick D.M."/>
<person name="Kastelein R.A."/>
<person name="de Waal Malefyt R."/>
<person name="Moore K.W."/>
</authorList>
<dbReference type="PubMed" id="12023369"/>
<dbReference type="DOI" id="10.4049/jimmunol.168.11.5699"/>
</citation>
<scope>INTERACTION WITH IL23R</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="3923" last="3930">
<title>Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.</title>
<authorList>
<person name="Shao H."/>
<person name="Cheng H.Y."/>
<person name="Cook R.G."/>
<person name="Tweardy D.J."/>
</authorList>
<dbReference type="PubMed" id="12873986"/>
</citation>
<scope>FUNCTION IN EGFR SIGNALING</scope>
<scope>INTERACTION WITH EGFR</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="Exp. Hematol." volume="31" first="398" last="405">
<title>Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway.</title>
<authorList>
<person name="Wierenga A.T."/>
<person name="Vogelzang I."/>
<person name="Eggen B.J."/>
<person name="Vellenga E."/>
</authorList>
<dbReference type="PubMed" id="12763138"/>
<dbReference type="DOI" id="10.1016/s0301-472x(03)00045-6"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-705 AND SER-727</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="36112" last="36120">
<title>Characterization of the signaling capacities of the novel gp130-like cytokine receptor.</title>
<authorList>
<person name="Dreuw A."/>
<person name="Radtke S."/>
<person name="Pflanz S."/>
<person name="Lippok B.E."/>
<person name="Heinrich P.C."/>
<person name="Hermanns H.M."/>
</authorList>
<dbReference type="PubMed" id="15194700"/>
<dbReference type="DOI" id="10.1074/jbc.m401122200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL31RA</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51697" last="51703">
<title>IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression.</title>
<authorList>
<person name="Huang Y."/>
<person name="Li T."/>
<person name="Sane D.C."/>
<person name="Li L."/>
</authorList>
<dbReference type="PubMed" id="15465816"/>
<dbReference type="DOI" id="10.1074/jbc.m410369200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-727 BY IRAK1</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="8908" last="8919">
<title>TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3.</title>
<authorList>
<person name="Perry E."/>
<person name="Tsruya R."/>
<person name="Levitsky P."/>
<person name="Pomp O."/>
<person name="Taller M."/>
<person name="Weisberg S."/>
<person name="Parris W."/>
<person name="Kulkarni S."/>
<person name="Malovani H."/>
<person name="Pawson T."/>
<person name="Shpungin S."/>
<person name="Nir U."/>
</authorList>
<dbReference type="PubMed" id="15467733"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208149"/>
</citation>
<scope>INTERACTION WITH TMF1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="5571" last="5577">
<title>Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.</title>
<authorList>
<person name="Manavathi B."/>
<person name="Nair S.S."/>
<person name="Wang R.-A."/>
<person name="Kumar R."/>
<person name="Vadlamudi R.K."/>
</authorList>
<dbReference type="PubMed" id="15994929"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-04-4664"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Int. Immunol." volume="17" first="1543" last="1552">
<title>Physical and functional interactions between STAT3 and ZIP kinase.</title>
<authorList>
<person name="Sato N."/>
<person name="Kawai T."/>
<person name="Sugiyama K."/>
<person name="Muromoto R."/>
<person name="Imoto S."/>
<person name="Sekine Y."/>
<person name="Ishida M."/>
<person name="Akira S."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="16219639"/>
<dbReference type="DOI" id="10.1093/intimm/dxh331"/>
</citation>
<scope>PHOSPHORYLATION AT SER-727 BY ZIPK/DAPK3</scope>
<scope>INTERACTION WITH ZIPK/DAPK3</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="13817" last="13823">
<title>Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation.</title>
<authorList>
<person name="Martens N."/>
<person name="Uzan G."/>
<person name="Wery M."/>
<person name="Hooghe R."/>
<person name="Hooghe-Peters E.L."/>
<person name="Gertler A."/>
</authorList>
<dbReference type="PubMed" id="15677474"/>
<dbReference type="DOI" id="10.1074/jbc.m411596200"/>
</citation>
<scope>INTERACTION WITH SOCS7</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-704 (ISOFORM DEL-701)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="4904" last="4912">
<title>Identification of STAT3 as a specific substrate of breast tumor kinase.</title>
<authorList>
<person name="Liu L."/>
<person name="Gao Y."/>
<person name="Qiu H."/>
<person name="Miller W.T."/>
<person name="Poli V."/>
<person name="Reich N.C."/>
</authorList>
<dbReference type="PubMed" id="16568091"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209501"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-705 BY PTK6</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="8828" last="8838">
<title>Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.</title>
<authorList>
<person name="Aziz M.H."/>
<person name="Manoharan H.T."/>
<person name="Church D.R."/>
<person name="Dreckschmidt N.E."/>
<person name="Zhong W."/>
<person name="Oberley T.D."/>
<person name="Wilding G."/>
<person name="Verma A.K."/>
</authorList>
<dbReference type="PubMed" id="17875724"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-1604"/>
</citation>
<scope>INTERACTION WITH PRKCE</scope>
<scope>PHOSPHORYLATION AT SER-727</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="8150" last="8155">
<title>STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.</title>
<authorList>
<person name="Liu L."/>
<person name="McBride K.M."/>
<person name="Reich N.C."/>
</authorList>
<dbReference type="PubMed" id="15919823"/>
<dbReference type="DOI" id="10.1073/pnas.0501643102"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR IMPORT MOTIF</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="13316" last="13325">
<title>leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.</title>
<authorList>
<person name="Saxena N.K."/>
<person name="Vertino P.M."/>
<person name="Anania F.A."/>
<person name="Sharma D."/>
</authorList>
<dbReference type="PubMed" id="17344214"/>
<dbReference type="DOI" id="10.1074/jbc.m609798200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF 434-GLU-GLU-435 AND TYR-705</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="37091" last="37102">
<title>The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression.</title>
<authorList>
<person name="Hou T."/>
<person name="Ray S."/>
<person name="Brasier A.R."/>
</authorList>
<dbReference type="PubMed" id="17956865"/>
<dbReference type="DOI" id="10.1074/jbc.m706458200"/>
</citation>
<scope>INTERACTION WITH CDK9</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="368" first="1" last="5">
<title>up-regulation of survivin by leptin/STAT3 signaling in MCF-7 cells.</title>
<authorList>
<person name="Jiang H."/>
<person name="Yu J."/>
<person name="Guo H."/>
<person name="Song H."/>
<person name="Chen S."/>
</authorList>
<dbReference type="PubMed" id="18242580"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.04.004"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Biochem. Pharmacol." volume="76" first="1389" last="1394">
<title>Role for DYRK family kinases on regulation of apoptosis.</title>
<authorList>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="18599021"/>
<dbReference type="DOI" id="10.1016/j.bcp.2008.05.021"/>
</citation>
<scope>PHOSPHORYLATION AT SER-727 BY DYRK2</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Blood" volume="111" first="2310" last="2320">
<title>Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts.</title>
<authorList>
<person name="Tauzin S."/>
<person name="Ding H."/>
<person name="Khatib K."/>
<person name="Ahmad I."/>
<person name="Burdevet D."/>
<person name="van Echten-Deckert G."/>
<person name="Lindquist J.A."/>
<person name="Schraven B."/>
<person name="Din N.U."/>
<person name="Borisch B."/>
<person name="Hoessli D.C."/>
</authorList>
<dbReference type="PubMed" id="18070987"/>
<dbReference type="DOI" id="10.1182/blood-2007-05-090985"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH LYN AND PAG1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Int. Immunol." volume="20" first="395" last="403">
<title>BART is essential for nuclear retention of STAT3.</title>
<authorList>
<person name="Muromoto R."/>
<person name="Sekine Y."/>
<person name="Imoto S."/>
<person name="Ikeda O."/>
<person name="Okayama T."/>
<person name="Sato N."/>
<person name="Matsuda T."/>
</authorList>
<dbReference type="PubMed" id="18234692"/>
<dbReference type="DOI" id="10.1093/intimm/dxm154"/>
</citation>
<scope>INTERACTION WITH ARL2BP</scope>
<scope>PHOSPHORYLATION AT SERINE RESIDUES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Mol. Cancer Res." volume="7" first="142" last="155">
<title>The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.</title>
<authorList>
<person name="Zoubeidi A."/>
<person name="Rocha J."/>
<person name="Zouanat F.Z."/>
<person name="Hamel L."/>
<person name="Scarlata E."/>
<person name="Aprikian A.G."/>
<person name="Chevalier S."/>
</authorList>
<dbReference type="PubMed" id="19147545"/>
<dbReference type="DOI" id="10.1158/1541-7786.mcr-08-0117"/>
</citation>
<scope>INTERACTION WITH FER</scope>
<scope>PHOSPHORYLATION BY FER</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="36129" last="36137">
<title>Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity.</title>
<authorList>
<person name="Wang H."/>
<person name="Holloway M.P."/>
<person name="Ma L."/>
<person name="Cooper Z.A."/>
<person name="Riolo M."/>
<person name="Samkari A."/>
<person name="Elenitoba-Johnson K.S."/>
<person name="Chin Y.E."/>
<person name="Altura R.A."/>
</authorList>
<dbReference type="PubMed" id="20826784"/>
<dbReference type="DOI" id="10.1074/jbc.m110.152777"/>
</citation>
<scope>INTERACTION WITH BIRC5/SURVIVIN</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5956" last="5966">
<title>Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.</title>
<authorList>
<person name="Chaix A."/>
<person name="Lopez S."/>
<person name="Voisset E."/>
<person name="Gros L."/>
<person name="Dubreuil P."/>
<person name="De Sepulveda P."/>
</authorList>
<dbReference type="PubMed" id="21135090"/>
<dbReference type="DOI" id="10.1074/jbc.m110.182642"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-705 IN RESPONSE TO KIT SIGNALING</scope>
<scope>PHOSPHORYLATION AT SER-727</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="Mol. Cell" volume="48" first="667" last="680">
<title>Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity.</title>
<authorList>
<person name="Shen S."/>
<person name="Niso-Santano M."/>
<person name="Adjemian S."/>
<person name="Takehara T."/>
<person name="Malik S.A."/>
<person name="Minoux H."/>
<person name="Souquere S."/>
<person name="Marino G."/>
<person name="Lachkar S."/>
<person name="Senovilla L."/>
<person name="Galluzzi L."/>
<person name="Kepp O."/>
<person name="Pierron G."/>
<person name="Maiuri M.C."/>
<person name="Hikita H."/>
<person name="Kroemer R."/>
<person name="Kroemer G."/>
</authorList>
<dbReference type="PubMed" id="23084476"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.09.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EIF2AK2</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-705; THR-714 AND SER-727</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-704 (ISOFORM DEL-701)</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="Sci. Rep." volume="4" first="7330" last="7330">
<title>Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity.</title>
<authorList>
<person name="Kim H.S."/>
<person name="Li A."/>
<person name="Ahn S."/>
<person name="Song H."/>
<person name="Zhang W."/>
</authorList>
<dbReference type="PubMed" id="25476455"/>
<dbReference type="DOI" id="10.1038/srep07330"/>
</citation>
<scope>INTERACTION WITH INPP5F</scope>
<scope>MUTAGENESIS OF TYR-705</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="Nature" volume="528" first="570" last="574">
<title>Germline variant FGFR4 p.G388R exposes a membrane-proximal STAT3 binding site.</title>
<authorList>
<person name="Ulaganathan V.K."/>
<person name="Sperl B."/>
<person name="Rapp U.R."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="26675719"/>
<dbReference type="DOI" id="10.1038/nature16449"/>
</citation>
<scope>INTERACTION WITH FGFR4</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2017" name="Mol. Cell" volume="65" first="296" last="309">
<title>Lysyl oxidase 3 is a dual-specificity enzyme involved in STAT3 deacetylation and deacetylimination modulation.</title>
<authorList>
<person name="Ma L."/>
<person name="Huang C."/>
<person name="Wang X.J."/>
<person name="Xin D.E."/>
<person name="Wang L.S."/>
<person name="Zou Q.C."/>
<person name="Zhang Y.S."/>
<person name="Tan M.D."/>
<person name="Wang Y.M."/>
<person name="Zhao T.C."/>
<person name="Chatterjee D."/>
<person name="Altura R.A."/>
<person name="Wang C."/>
<person name="Xu Y.S."/>
<person name="Yang J.H."/>
<person name="Fan Y.S."/>
<person name="Han B.H."/>
<person name="Si J."/>
<person name="Zhang X."/>
<person name="Cheng J."/>
<person name="Chang Z."/>
<person name="Chin Y.E."/>
</authorList>
<dbReference type="PubMed" id="28065600"/>
<dbReference type="DOI" id="10.1016/j.molcel.2016.12.002"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>ALLYSINE AT LYS-601; LYS-615; LYS-631 AND LYS-685</scope>
<scope>ACETYLATION AT LYS-601; LYS-615; LYS-631; LYS-685 AND LYS-707</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2018" name="Cell Rep." volume="23" first="3525" last="3536">
<title>Salmonella Activation of STAT3 Signaling by SarA Effector Promotes Intracellular Replication and Production of IL-10.</title>
<authorList>
<person name="Jaslow S.L."/>
<person name="Gibbs K.D."/>
<person name="Fricke W.F."/>
<person name="Wang L."/>
<person name="Pittman K.J."/>
<person name="Mammel M.K."/>
<person name="Thaden J.T."/>
<person name="Fowler V.G. Jr."/>
<person name="Hammer G.E."/>
<person name="Elfenbein J.R."/>
<person name="Ko D.C."/>
</authorList>
<dbReference type="PubMed" id="29924996"/>
<dbReference type="DOI" id="10.1016/j.celrep.2018.05.072"/>
</citation>
<scope>INTERACTION WITH S.TYPHIMURIUM SARA (MICROBIAL INFECTION)</scope>
<scope>PHOSPHORYLATION AT TYR-705 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2019" name="Nature" volume="573" first="139" last="143">
<title>Fatty acids and cancer-amplified ZDHHC19 promote STAT3 activation through S-palmitoylation.</title>
<authorList>
<person name="Niu J."/>
<person name="Sun Y."/>
<person name="Chen B."/>
<person name="Zheng B."/>
<person name="Jarugumilli G.K."/>
<person name="Walker S.R."/>
<person name="Hata A.N."/>
<person name="Mino-Kenudson M."/>
<person name="Frank D.A."/>
<person name="Wu X."/>
</authorList>
<dbReference type="PubMed" id="31462771"/>
<dbReference type="DOI" id="10.1038/s41586-019-1511-x"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ZDHHC19</scope>
<scope>STEAROYLATION</scope>
<scope>PALMITOYLATION AT CYS-687 AND CYS-712</scope>
<scope>PHOSPHORYLATION AT TYR-705</scope>
<scope>MUTAGENESIS OF ALA-651; CYS-687; TYR-705 AND CYS-712</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2020" name="Immunol. Lett." volume="219" first="8" last="14">
<title>Prohibitin 1 interacts with signal transducer and activator of transcription 3 in T-helper 17 cells.</title>
<authorList>
<person name="Zhang J."/>
<person name="Sun Z."/>
<person name="Wu Q."/>
<person name="Shen J."/>
</authorList>
<dbReference type="PubMed" id="31899195"/>
<dbReference type="DOI" id="10.1016/j.imlet.2019.12.008"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PHB</scope>
<scope>PHOSPHORYLATION AT TYR-705 AND SER-727</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2007" name="N. Engl. J. Med." volume="357" first="1608" last="1619">
<title>STAT3 mutations in the hyper-IgE syndrome.</title>
<authorList>
<person name="Holland S.M."/>
<person name="DeLeo F.R."/>
<person name="Elloumi H.Z."/>
<person name="Hsu A.P."/>
<person name="Uzel G."/>
<person name="Brodsky N."/>
<person name="Freeman A.F."/>
<person name="Demidowich A."/>
<person name="Davis J."/>
<person name="Turner M.L."/>
<person name="Anderson V.L."/>
<person name="Darnell D.N."/>
<person name="Welch P.A."/>
<person name="Kuhns D.B."/>
<person name="Frucht D.M."/>
<person name="Malech H.L."/>
<person name="Gallin J.I."/>
<person name="Kobayashi S.D."/>
<person name="Whitney A.R."/>
<person name="Voyich J.M."/>
<person name="Musser J.M."/>
<person name="Woellner C."/>
<person name="Schaffer A.A."/>
<person name="Puck J.M."/>
<person name="Grimbacher B."/>
</authorList>
<dbReference type="PubMed" id="17881745"/>
<dbReference type="DOI" id="10.1056/nejmoa073687"/>
</citation>
<scope>VARIANTS HIES1 GLN-382; LEU-382; TRP-382; LEU-384; SER-384; GLN-423; VAL-463 DEL; ASN-611; VAL-621; ILE-622; LEU-637; MET-637; GLN-644 DEL AND CYS-657</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2007" name="Nature" volume="448" first="1058" last="1062">
<title>Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.</title>
<authorList>
<person name="Minegishi Y."/>
<person name="Saito M."/>
<person name="Tsuchiya S."/>
<person name="Tsuge I."/>
<person name="Takada H."/>
<person name="Hara T."/>
<person name="Kawamura N."/>
<person name="Ariga T."/>
<person name="Pasic S."/>
<person name="Stojkovic O."/>
<person name="Metin A."/>
<person name="Karasuyama H."/>
</authorList>
<dbReference type="PubMed" id="17676033"/>
<dbReference type="DOI" id="10.1038/nature06096"/>
</citation>
<scope>VARIANTS HIES1 GLN-382; TRP-382; ILE-389; TYR-437 AND VAL-463 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS HIES1 GLN-382; TRP-382; ILE-389; TYR-437 AND VAL-463 DEL</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Allergy Rhinol. (Providence)" volume="3" first="E94" last="E97">
<title>Signal transducer and activator of transcription 3 mutation with invasive eosinophilic disease.</title>
<authorList>
<person name="Crosby K."/>
<person name="Swender D."/>
<person name="Chernin L."/>
<person name="Hafez-Khayyata S."/>
<person name="Ochs H."/>
<person name="Tcheurekdjian H."/>
<person name="Hostoffer R."/>
</authorList>
<dbReference type="PubMed" id="23342295"/>
<dbReference type="DOI" id="10.2500/ar.2012.3.0035"/>
</citation>
<scope>VARIANT HIES1 ILE-389</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2014" name="Nat. Genet." volume="46" first="812" last="814">
<title>Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.</title>
<authorList>
<person name="Flanagan S.E."/>
<person name="Haapaniemi E."/>
<person name="Russell M.A."/>
<person name="Caswell R."/>
<person name="Lango Allen H."/>
<person name="De Franco E."/>
<person name="McDonald T.J."/>
<person name="Rajala H."/>
<person name="Ramelius A."/>
<person name="Barton J."/>
<person name="Heiskanen K."/>
<person name="Heiskanen-Kosma T."/>
<person name="Kajosaari M."/>
<person name="Murphy N.P."/>
<person name="Milenkovic T."/>
<person name="Seppaenen M."/>
<person name="Lernmark A."/>
<person name="Mustjoki S."/>
<person name="Otonkoski T."/>
<person name="Kere J."/>
<person name="Morgan N.G."/>
<person name="Ellard S."/>
<person name="Hattersley A.T."/>
</authorList>
<dbReference type="PubMed" id="25038750"/>
<dbReference type="DOI" id="10.1038/ng.3040"/>
</citation>
<scope>VARIANTS ADMIO1 ARG-392; LYS-646; ASN-658 AND MET-716</scope>
<scope>INVOLVEMENT IN ADMIO1</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2016" name="Clin. Genet." volume="89" first="217" last="221">
<title>Functional characterization of two new STAT3 mutations associated with hyper-IgE syndrome in a Mexican cohort.</title>
<authorList>
<person name="Alcantara-Montiel J.C."/>
<person name="Staines-Boone T."/>
<person name="Lopez-Herrera G."/>
<person name="Espinosa-Rosales F."/>
<person name="Espinosa-Padilla S.E."/>
<person name="Hernandez-Rivas R."/>
<person name="Santos-Argumedo L."/>
</authorList>
<dbReference type="PubMed" id="26293184"/>
<dbReference type="DOI" id="10.1111/cge.12658"/>
</citation>
<scope>VARIANTS HIES1 TRP-382; TYR-395; TYR-425; MET-637 AND CYS-657</scope>
<scope>CHARACTERIZATION OF VARIANTS HIES1 TRP-382; TYR-395; TYR-425; MET-637 AND CYS-657</scope>
<scope>PHOSPHORYLATION AT TYR-705 AND SER-727</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2017" name="Diabetes" volume="66" first="1022" last="1029">
<title>An activating mutation in STAT3 results in neonatal diabetes through reduced insulin synthesis.</title>
<authorList>
<person name="Velayos T."/>
<person name="Martinez R."/>
<person name="Alonso M."/>
<person name="Garcia-Etxebarria K."/>
<person name="Aguayo A."/>
<person name="Camarero C."/>
<person name="Urrutia I."/>
<person name="Martinez de LaPiscina I."/>
<person name="Barrio R."/>
<person name="Santin I."/>
<person name="Castano L."/>
</authorList>
<dbReference type="PubMed" id="28073828"/>
<dbReference type="DOI" id="10.2337/db16-0867"/>
</citation>
<scope>VARIANT ADMIO1 SER-330</scope>
<scope>CHARACTERIZATION OF VARIANT ADMIO1 SER-330</scope>
</reference>
<comment type="function">
<text evidence="10 13 17 19 20 27 34 39 45">Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF, LEP and other growth factors (PubMed:10688651, PubMed:12359225, PubMed:12873986, PubMed:15194700, PubMed:17344214, PubMed:18242580, PubMed:23084476, PubMed:31462771). Once activated, recruits coactivators, such as NCOA1 or MED1, to the promoter region of the target gene (PubMed:17344214). May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4 (PubMed:12873986). Upon activation of IL6ST/gp130 signaling by interleukin-6 (IL6), binds to the IL6-responsive elements identified in the promoters of various acute-phase protein genes (PubMed:12359225). Activated by IL31 through IL31RA (PubMed:15194700). Acts as a regulator of inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 or regulatory T-cells (Treg): deacetylation and oxidation of lysine residues by LOXL3, leads to disrupt STAT3 dimerization and inhibit its transcription activity (PubMed:28065600). Involved in cell cycle regulation by inducing the expression of key genes for the progression from G1 to S phase, such as CCND1 (PubMed:17344214). Mediates the effects of LEP on melanocortin production, body energy homeostasis and lactation (By similarity). May play an apoptotic role by transctivating BIRC5 expression under LEP activation (PubMed:18242580). Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity (PubMed:23084476). Plays a crucial role in basal beta cell functions, such as regulation of insulin secretion (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="10 11 13 14 15 19 20 22 23 24 25 27 29 31 32 33 36 37 39 42 44 45 48 49 52">Forms a homodimer or a heterodimer with a related family member (at least STAT1) (PubMed:28065600). Interacts with IL31RA, NCOA1, PELP1, SIPAR, SOCS7, STATIP1 and TMF1 (PubMed:15994929, PubMed:15194700, PubMed:17344214, PubMed:15677474, PubMed:15467733) (By similarity). Interacts with IL23R in presence of IL23 (PubMed:12023369). Interacts (via SH2 domain) with NLK. Interacts with ARL2BP; the interaction is enhanced by LIF and JAK1 expression (By similarity). Interacts with KPNA4 and KPNA5; KPNA4 may be the primary mediator of nuclear import (By similarity). Interacts with CAV2; the interaction is increased on insulin-induced tyrosine phosphorylation of CAV2 and leads to STAT3 activation (By similarity). Interacts with ARL2BP; interaction is enhanced with ARL2 (PubMed:18234692). Interacts with NEK6 (By similarity). Binds to CDK9 when activated and nuclear (PubMed:17956865). Interacts with BMX (PubMed:10688651). Interacts with ZIPK/DAPK3 (PubMed:16219639). Interacts with PIAS3; the interaction occurs on stimulation by IL6, CNTF or OSM and inhibits the DNA binding activity of STAT3 (PubMed:9388184). In prostate cancer cells, interacts with STAT3 and promotes DNA binding activity of STAT3. Interacts with STMN3, antagonizing its microtubule-destabilizing activity. Interacts with the 'Lys-129' acetylated form of BIRC5/survivin (PubMed:20826784). Interacts with FER (PubMed:19147545). Interacts (via SH2 domain) with EIF2AK2/PKR (via the kinase catalytic domain) (PubMed:23084476). Interacts with STAT3; the interaction is independent of STAT3 Tyr-705 phosphorylation status (PubMed:25476455). Interacts with FGFR4 (PubMed:26675719). Interacts with OCAD1 (By similarity). Interacts with ZDHHC19, leading to palmitoylation which promotes homodimerization and activation (PubMed:31462771). Interacts (unphosphorylated or phosphorylated at Ser-727) with PHB (PubMed:31899195).</text>
</comment>
<comment type="subunit">
<text evidence="16">(Microbial infection) Interacts with HCV core protein.</text>
</comment>
<comment type="subunit">
<text evidence="47">(Microbial infection) Interacts with S.typhimurium SarA.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1046765">
<id>O14874</id>
<label>BCKDK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1104509">
<id>Q96G01</id>
<label>BICD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-696657">
<id>P51813</id>
<label>BMX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1542113">
<id>P07384</id>
<label>CAPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1383449">
<id>P50750</id>
<label>CDK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1046676">
<id>P31146</id>
<label>CORO1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-7331284">
<id>Q99062</id>
<label>CSF3R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-77321">
<id>Q9UER7</id>
<label>DAXX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-6139214">
<id>O95661</id>
<label>DIRAS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-711968">
<id>Q13011</id>
<label>ECH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-719602">
<id>P30084</id>
<label>ECHS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-530054">
<id>Q15910</id>
<label>EZH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-372506">
<id>Q8TAE8</id>
<label>GADD45GIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-641642">
<id>Q9BVP2</id>
<label>GNL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-353389">
<id>P12268</id>
<label>IMPDH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1383438">
<id>P23458</id>
<label>JAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1364">
<id>Q07666</id>
<label>KHDRBS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-739696">
<id>P25791</id>
<label>LMO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-358684">
<id>O43318</id>
<label>MAP3K7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-713568">
<id>P45984</id>
<label>MAPK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-713586">
<id>P45984-1</id>
<label>MAPK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-3940432">
<id>Q8TE76</id>
<label>MORC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-720602">
<id>Q92665</id>
<label>MRPS31</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-20559045">
<id>Q14938-3</id>
<label>NFIX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-20558886">
<id>Q14938-4</id>
<label>NFIX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-721550">
<id>P22736</id>
<label>NR4A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-3940481">
<id>Q9ULD0</id>
<label>OGDHL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-78539">
<id>P06401</id>
<label>PGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-11956563">
<id>Q96HA1-2</id>
<label>POM121</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1266300">
<id>P32119</id>
<label>PRDX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-2480756">
<id>P07949</id>
<label>RET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-366288">
<id>O75116</id>
<label>ROCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-351206">
<id>P46781</id>
<label>RPS9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-2935583">
<id>O00570</id>
<label>SOX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-298336">
<id>P08047</id>
<label>SP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-750459">
<id>P30626</id>
<label>SRI</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-3921363">
<id>Q06520</id>
<label>SULT2A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-22225085">
<id>Q810M5</id>
<label>Zdhhc19</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-518675">
<id>P40763</id>
</interactant>
<interactant intactId="EBI-7971837">
<id>Q9DUM3</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="45 48 49">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="45 48 49">Nucleus</location>
</subcellularLocation>
<text>Shuttles between the nucleus and the cytoplasm. Translocated into the nucleus upon tyrosine phosphorylation and dimerization, in response to signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Constitutive nuclear presence is independent of tyrosine phosphorylation. Predominantly present in the cytoplasm without stimuli. Upon leukemia inhibitory factor (LIF) stimulation, accumulates in the nucleus. The complex composed of BART and ARL2 plays an important role in the nuclear translocation and retention of STAT3. Identified in a complex with LYN and PAG1.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P40763-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P40763-2</id>
<name>Del-701</name>
<sequence type="described" ref="VSP_010474"/>
</isoform>
<isoform>
<id>P40763-3</id>
<name>3</name>
<sequence type="described" ref="VSP_055918 VSP_055919"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="49">Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Expressed in naive CD4(+) T cells as well as T-helper Th17, Th1 and Th2 cells (PubMed:31899195).</text>
</comment>
<comment type="induction">
<text evidence="48">Positive feedback loop through phosphorylation and palmitoylation in response to stimulation with palmitic acid and cytokines.</text>
</comment>
<comment type="PTM">
<text evidence="10 13 17 18 21 25 26 27 29 33 35 36 38 48 51">Tyrosine phosphorylated upon stimulation with EGF. Tyrosine phosphorylated in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Activated through tyrosine phosphorylation by BMX. Tyrosine phosphorylated in response to IL6, IL11, LIF, CNTF, KITLG/SCF, CSF1, EGF, PDGF, IFN-alpha, LEP and OSM. Activated KIT promotes phosphorylation on tyrosine residues and subsequent translocation to the nucleus. Phosphorylated on serine upon DNA damage, probably by ATM or ATR. Serine phosphorylation is important for the formation of stable DNA-binding STAT3 homodimers and maximal transcriptional activity. ARL2BP may participate in keeping the phosphorylated state of STAT3 within the nucleus. Upon LPS challenge, phosphorylated within the nucleus by IRAK1. Upon erythropoietin treatment, phosphorylated on Ser-727 by RPS6KA5. Phosphorylation at Tyr-705 by PTK6 or FER leads to an increase of its transcriptional activity (PubMed:12763138, PubMed:16568091, PubMed:21135090, PubMed:31462771). Dephosphorylation on tyrosine residues by PTPN2 negatively regulates IL6/interleukin-6 signaling.</text>
</comment>
<comment type="PTM">
<text evidence="45">Acetylated on lysine residues by CREBBP. Deacetylation by LOXL3 leads to disrupt STAT3 dimerization and inhibit STAT3 transcription activity (PubMed:28065600). Oxidation of lysine residues to allysine on STAT3 preferentially takes place on lysine residues that are acetylated (PubMed:28065600).</text>
</comment>
<comment type="PTM">
<text evidence="45">Some lysine residues are oxidized to allysine by LOXL3, leading to disrupt STAT3 dimerization and inhibit STAT3 transcription activity (PubMed:28065600). Oxidation of lysine residues to allysine on STAT3 preferentially takes place on lysine residues that are acetylated (PubMed:28065600).</text>
</comment>
<comment type="PTM">
<text evidence="47">(Microbial infection) Phosphorylated on Tyr-705 in the presence of S.typhimurium SarA.</text>
</comment>
<comment type="PTM">
<text evidence="48">S-palmitoylated by ZDHHC19 in SH2 putative lipid-binding pockets, leading to homodimerization (PubMed:31462771). Nuclear STAT3 is highly palmitoylated (about 75%) compared with cytoplasmic STAT3 (about 20%) (PubMed:31462771).</text>
</comment>
<comment type="PTM">
<text evidence="48 57">S-stearoylated, probably by ZDHHC19.</text>
</comment>
<comment type="disease" evidence="28 30 40 43">
<disease id="DI-01767">
<name>Hyper-IgE recurrent infection syndrome 1, autosomal dominant</name>
<acronym>HIES1</acronym>
<description>A rare disorder of immunity and connective tissue characterized by immunodeficiency, chronic eosinophilia, distinctive coarse facial appearance, abnormal dentition, hyperextensibility of the joints, and bone fractures.</description>
<dbReference type="MIM" id="147060"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="41 46">
<disease id="DI-04194">
<name>Autoimmune disease, multisystem, infantile-onset, 1</name>
<acronym>ADMIO1</acronym>
<description>A disorder characterized by early childhood onset of a spectrum of autoimmune manifestations affecting multiple organs, including insulin-dependent diabetes mellitus and autoimmune enteropathy or celiac disease. Other features include short stature, non-specific dermatitis, hypothyroidism, autoimmune arthritis, and delayed puberty.</description>
<dbReference type="MIM" id="615952"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Involved in the gp130-mediated signaling pathway.</text>
</comment>
<comment type="similarity">
<text evidence="56">Belongs to the transcription factor STAT family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/STAT3"/>
<text>STAT3 entry</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/STAT3ID444.html"/>
</comment>
<comment type="online information" name="STAT3base">
<link uri="http://structure.bmc.lu.se/idbase/STAT3base/"/>
<text>STAT3 mutation db</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/stat3/"/>
</comment>
<dbReference type="EMBL" id="L29277">
<property type="protein sequence ID" value="AAA58374.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ012463">
<property type="protein sequence ID" value="CAA10032.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="JB252046">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291933">
<property type="protein sequence ID" value="BAF84622.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY572796">
<property type="protein sequence ID" value="AAS66986.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC087691">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471152">
<property type="protein sequence ID" value="EAW60822.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000627">
<property type="protein sequence ID" value="AAH00627.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014482">
<property type="protein sequence ID" value="AAH14482.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF029311">
<property type="protein sequence ID" value="AAB84254.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32656.1">
<molecule id="P40763-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32657.1">
<molecule id="P40763-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS59288.1">
<molecule id="P40763-3"/>
</dbReference>
<dbReference type="PIR" id="A54444">
<property type="entry name" value="A54444"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003141.2">
<molecule id="P40763-2"/>
<property type="nucleotide sequence ID" value="NM_003150.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_644805.1">
<molecule id="P40763-1"/>
<property type="nucleotide sequence ID" value="NM_139276.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_998827.1">
<molecule id="P40763-3"/>
<property type="nucleotide sequence ID" value="NM_213662.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005257673.2">
<property type="nucleotide sequence ID" value="XM_005257616.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005257674.2">
<property type="nucleotide sequence ID" value="XM_005257617.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011523447.1">
<property type="nucleotide sequence ID" value="XM_011525145.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011523448.1">
<property type="nucleotide sequence ID" value="XM_011525146.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880461.1">
<property type="nucleotide sequence ID" value="XM_017024972.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016880464.1">
<property type="nucleotide sequence ID" value="XM_017024975.1"/>
</dbReference>
<dbReference type="PDB" id="5AX3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="B=571-582"/>
</dbReference>
<dbReference type="PDB" id="5U5S">
<property type="method" value="NMR"/>
<property type="chains" value="B=81-92"/>
</dbReference>
<dbReference type="PDB" id="6NJS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=127-688"/>
</dbReference>
<dbReference type="PDB" id="6NUQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15"/>
<property type="chains" value="A=127-688"/>
</dbReference>
<dbReference type="PDB" id="6QHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A/B=127-715"/>
</dbReference>
<dbReference type="PDB" id="6TLC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=127-722"/>
</dbReference>
<dbReference type="PDBsum" id="5AX3"/>
<dbReference type="PDBsum" id="5U5S"/>
<dbReference type="PDBsum" id="6NJS"/>
<dbReference type="PDBsum" id="6NUQ"/>
<dbReference type="PDBsum" id="6QHD"/>
<dbReference type="PDBsum" id="6TLC"/>
<dbReference type="SMR" id="P40763"/>
<dbReference type="BioGRID" id="112651">
<property type="interactions" value="285"/>
</dbReference>
<dbReference type="CORUM" id="P40763"/>
<dbReference type="DIP" id="DIP-33584N"/>
<dbReference type="ELM" id="P40763"/>
<dbReference type="IntAct" id="P40763">
<property type="interactions" value="208"/>
</dbReference>
<dbReference type="MINT" id="P40763"/>
<dbReference type="STRING" id="9606.ENSP00000264657"/>
<dbReference type="BindingDB" id="P40763"/>
<dbReference type="ChEMBL" id="CHEMBL4026"/>
<dbReference type="DrugBank" id="DB05959">
<property type="generic name" value="ENMD-1198"/>
</dbReference>
<dbReference type="DrugCentral" id="P40763"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2994"/>
<dbReference type="MoonDB" id="P40763">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="GlyGen" id="P40763">
<property type="glycosylation" value="2 sites, 1 O-linked glycan (2 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P40763"/>
<dbReference type="MetOSite" id="P40763"/>
<dbReference type="PhosphoSitePlus" id="P40763"/>
<dbReference type="SwissPalm" id="P40763"/>
<dbReference type="BioMuta" id="STAT3"/>
<dbReference type="DMDM" id="48429227"/>
<dbReference type="CPTAC" id="CPTAC-1275"/>
<dbReference type="CPTAC" id="CPTAC-1276"/>
<dbReference type="CPTAC" id="CPTAC-1751"/>
<dbReference type="EPD" id="P40763"/>
<dbReference type="jPOST" id="P40763"/>
<dbReference type="MassIVE" id="P40763"/>
<dbReference type="MaxQB" id="P40763"/>
<dbReference type="PaxDb" id="P40763"/>
<dbReference type="PeptideAtlas" id="P40763"/>
<dbReference type="PRIDE" id="P40763"/>
<dbReference type="ProteomicsDB" id="55378">
<molecule id="P40763-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55379">
<molecule id="P40763-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="660">
<property type="antibodies" value="2384 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="6774"/>
<dbReference type="Ensembl" id="ENST00000264657">
<molecule id="P40763-1"/>
<property type="protein sequence ID" value="ENSP00000264657"/>
<property type="gene ID" value="ENSG00000168610"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000404395">
<molecule id="P40763-2"/>
<property type="protein sequence ID" value="ENSP00000384943"/>
<property type="gene ID" value="ENSG00000168610"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000585517">
<molecule id="P40763-3"/>
<property type="protein sequence ID" value="ENSP00000467000"/>
<property type="gene ID" value="ENSG00000168610"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000588969">
<molecule id="P40763-1"/>
<property type="protein sequence ID" value="ENSP00000467985"/>
<property type="gene ID" value="ENSG00000168610"/>
</dbReference>
<dbReference type="GeneID" id="6774"/>
<dbReference type="KEGG" id="hsa:6774"/>
<dbReference type="UCSC" id="uc002hzl.2">
<molecule id="P40763-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6774"/>
<dbReference type="DisGeNET" id="6774"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000168610.14"/>
<dbReference type="GeneCards" id="STAT3"/>
<dbReference type="GeneReviews" id="STAT3"/>
<dbReference type="HGNC" id="HGNC:11364">
<property type="gene designation" value="STAT3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000168610">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="STAT3"/>
<dbReference type="MIM" id="102582">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="147060">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615952">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P40763"/>
<dbReference type="OpenTargets" id="ENSG00000168610"/>
<dbReference type="Orphanet" id="520">
<property type="disease" value="Acute promyelocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="2314">
<property type="disease" value="Autosomal dominant hyper-IgE syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="512017">
<property type="disease" value="Chronic lymphoproliferative disorder of natural killer cells"/>
</dbReference>
<dbReference type="Orphanet" id="99885">
<property type="disease" value="Permanent neonatal diabetes mellitus"/>
</dbReference>
<dbReference type="Orphanet" id="438159">
<property type="disease" value="STAT3-related early-onset multisystem autoimmune disease"/>
</dbReference>
<dbReference type="Orphanet" id="86872">
<property type="disease" value="T-cell large granular lymphocyte leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA337"/>
<dbReference type="eggNOG" id="KOG3667">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00990000203599"/>
<dbReference type="HOGENOM" id="CLU_014189_3_0_1"/>
<dbReference type="InParanoid" id="P40763"/>
<dbReference type="KO" id="K04692"/>
<dbReference type="OMA" id="GKYCRSE"/>
<dbReference type="OrthoDB" id="327469at2759"/>
<dbReference type="PhylomeDB" id="P40763"/>
<dbReference type="TreeFam" id="TF318648"/>
<dbReference type="PathwayCommons" id="P40763"/>
<dbReference type="Reactome" id="R-HSA-1059683">
<property type="pathway name" value="Interleukin-6 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111453">
<property type="pathway name" value="BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1266695">
<property type="pathway name" value="Interleukin-7 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1839117">
<property type="pathway name" value="Signaling by cytosolic FGFR1 fusion mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198745">
<property type="pathway name" value="Signalling to STAT3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2586552">
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2892247">
<property type="pathway name" value="POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-390471">
<property type="pathway name" value="Association of TriC/CCT with target proteins during biosynthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-452723">
<property type="pathway name" value="Transcriptional regulation of pluripotent stem cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6783783">
<property type="pathway name" value="Interleukin-10 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849474">
<property type="pathway name" value="PTK6 Activates STAT3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854691">
<property type="pathway name" value="Interleukin-20 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875791">
<property type="pathway name" value="MET activates STAT3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8983432">
<property type="pathway name" value="Interleukin-15 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8984722">
<property type="pathway name" value="Interleukin-35 Signalling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8985947">
<property type="pathway name" value="Interleukin-9 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9008059">
<property type="pathway name" value="Interleukin-37 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020933">
<property type="pathway name" value="Interleukin-23 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020956">
<property type="pathway name" value="Interleukin-27 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9020958">
<property type="pathway name" value="Interleukin-21 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673767">
<property type="pathway name" value="Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9673770">
<property type="pathway name" value="Signaling by PDGFRA extracellular domain mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-982772">
<property type="pathway name" value="Growth hormone receptor signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P40763"/>
<dbReference type="SIGNOR" id="P40763"/>
<dbReference type="BioGRID-ORCS" id="6774">
<property type="hits" value="20 hits in 906 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="STAT3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="STAT3"/>
<dbReference type="GenomeRNAi" id="6774"/>
<dbReference type="Pharos" id="P40763">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P40763"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P40763">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000168610">
<property type="expression patterns" value="Expressed in upper lobe of lung and 250 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P40763">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P40763">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005743">
<property type="term" value="C:mitochondrial inner membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005667">
<property type="term" value="C:transcription regulator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031730">
<property type="term" value="F:CCR5 chemokine receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0035259">
<property type="term" value="F:glucocorticoid receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070878">
<property type="term" value="F:primary miRNA binding"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001103">
<property type="term" value="F:RNA polymerase II repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006953">
<property type="term" value="P:acute-phase response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048708">
<property type="term" value="P:astrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071345">
<property type="term" value="P:cellular response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032870">
<property type="term" value="P:cellular response to hormone stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044320">
<property type="term" value="P:cellular response to leptin stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071407">
<property type="term" value="P:cellular response to organic cyclic compound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006952">
<property type="term" value="P:defense response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042755">
<property type="term" value="P:eating behavior"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097009">
<property type="term" value="P:energy homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001754">
<property type="term" value="P:eye photoreceptor cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060396">
<property type="term" value="P:growth hormone receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060397">
<property type="term" value="P:growth hormone receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035723">
<property type="term" value="P:interleukin-15-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038114">
<property type="term" value="P:interleukin-21-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038155">
<property type="term" value="P:interleukin-23-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070106">
<property type="term" value="P:interleukin-27-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070757">
<property type="term" value="P:interleukin-35-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070102">
<property type="term" value="P:interleukin-6-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038111">
<property type="term" value="P:interleukin-7-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038113">
<property type="term" value="P:interleukin-9-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030522">
<property type="term" value="P:intracellular receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033210">
<property type="term" value="P:leptin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042789">
<property type="term" value="P:mRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010507">
<property type="term" value="P:negative regulation of autophagy"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045820">
<property type="term" value="P:negative regulation of glycolytic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010730">
<property type="term" value="P:negative regulation of hydrogen peroxide biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001223">
<property type="term" value="P:negative regulation of neuron migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000635">
<property type="term" value="P:negative regulation of primary miRNA processing"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000737">
<property type="term" value="P:negative regulation of stem cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016310">
<property type="term" value="P:phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045766">
<property type="term" value="P:positive regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001171">
<property type="term" value="P:positive regulation of ATP biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900017">
<property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045648">
<property type="term" value="P:positive regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000637">
<property type="term" value="P:positive regulation of gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902728">
<property type="term" value="P:positive regulation of growth factor dependent skeletal muscle satellite cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032733">
<property type="term" value="P:positive regulation of interleukin-10 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032755">
<property type="term" value="P:positive regulation of interleukin-6 production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904685">
<property type="term" value="P:positive regulation of metalloendopeptidase activity"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905618">
<property type="term" value="P:positive regulation of miRNA mediated inhibition of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045747">
<property type="term" value="P:positive regulation of Notch signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902895">
<property type="term" value="P:positive regulation of pri-miRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042535">
<property type="term" value="P:positive regulation of tumor necrosis factor biosynthetic process"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904469">
<property type="term" value="P:positive regulation of tumor necrosis factor secretion"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1905564">
<property type="term" value="P:positive regulation of vascular endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0099527">
<property type="term" value="P:postsynapse to nucleus signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006606">
<property type="term" value="P:protein import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060019">
<property type="term" value="P:radial glial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060259">
<property type="term" value="P:regulation of feeding behavior"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046902">
<property type="term" value="P:regulation of mitochondrial membrane permeability"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0040014">
<property type="term" value="P:regulation of multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032355">
<property type="term" value="P:response to estradiol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044321">
<property type="term" value="P:response to leptin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019953">
<property type="term" value="P:sexual reproduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0035019">
<property type="term" value="P:somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0072540">
<property type="term" value="P:T-helper 17 cell lineage commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072538">
<property type="term" value="P:T-helper 17 type immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001659">
<property type="term" value="P:temperature homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd10374">
<property type="entry name" value="SH2_STAT3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.532.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.630">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR008967">
<property type="entry name" value="p53-like_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001217">
<property type="entry name" value="STAT"/>
</dbReference>
<dbReference type="InterPro" id="IPR035855">
<property type="entry name" value="STAT3_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036535">
<property type="entry name" value="STAT_N_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013800">
<property type="entry name" value="STAT_TF_alpha"/>
</dbReference>
<dbReference type="InterPro" id="IPR015988">
<property type="entry name" value="STAT_TF_coiled-coil"/>
</dbReference>
<dbReference type="InterPro" id="IPR013801">
<property type="entry name" value="STAT_TF_DNA-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR012345">
<property type="entry name" value="STAT_TF_DNA-bd_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR013799">
<property type="entry name" value="STAT_TF_prot_interaction"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11801">
<property type="entry name" value="PTHR11801"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01017">
<property type="entry name" value="STAT_alpha"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02864">
<property type="entry name" value="STAT_bind"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02865">
<property type="entry name" value="STAT_int"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00964">
<property type="entry name" value="STAT_int"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47655">
<property type="entry name" value="SSF47655"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48092">
<property type="entry name" value="SSF48092"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49417">
<property type="entry name" value="SSF49417"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="initiator methionine" description="Removed" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Signal transducer and activator of transcription 3" id="PRO_0000182417">
<location>
<begin position="2"/>
<end position="770"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="12">
<location>
<begin position="580"/>
<end position="670"/>
</location>
</feature>
<feature type="short sequence motif" description="Essential for nuclear import">
<location>
<begin position="150"/>
<end position="162"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Allysine; alternate" evidence="45">
<location>
<position position="601"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="45">
<location>
<position position="601"/>
</location>
</feature>
<feature type="modified residue" description="Allysine; alternate" evidence="45">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="45">
<location>
<position position="615"/>
</location>
</feature>
<feature type="modified residue" description="Allysine; alternate" evidence="45">
<location>
<position position="631"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="45">
<location>
<position position="631"/>
</location>
</feature>
<feature type="modified residue" description="Allysine; alternate" evidence="45">
<location>
<position position="685"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="45">
<location>
<position position="685"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FER and PTK6" evidence="3 9 18 26 38 43 48 49">
<location>
<position position="705"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="45">
<location>
<position position="707"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="714"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2, NLK, NEK6, IRAK1, RPS6KA5, ZIPK/DAPK3 and PKC/PRKCE" evidence="4 5 6 8 9 18 21 25 29 35 38 43 49">
<location>
<position position="727"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="48">
<location>
<position position="687"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="48">
<location>
<position position="712"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Del-701." id="VSP_010474" evidence="54">
<location>
<position position="701"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055918" evidence="55">
<original>TTCSNTI</original>
<variation>FIDAVWK</variation>
<location>
<begin position="716"/>
<end position="722"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_055919" evidence="55">
<location>
<begin position="723"/>
<end position="770"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1803125." id="VAR_018683">
<original>Q</original>
<variation>K</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17878478." id="VAR_018679" evidence="53">
<original>M</original>
<variation>I</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO1; increases transcriptional activity; increases binding to ISL1 promoter region; decreases glucose stimulated insulin secretion." id="VAR_078445" evidence="46">
<original>P</original>
<variation>S</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; dbSNP:rs113994136." id="VAR_037365" evidence="30">
<original>R</original>
<variation>L</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; loss of function; dbSNP:rs113994136." id="VAR_037366" evidence="28 30">
<original>R</original>
<variation>Q</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; loss of function; reduced DNA-binding ability; dbSNP:rs113994135." id="VAR_037367" evidence="28 30 43">
<original>R</original>
<variation>W</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037368" evidence="30">
<original>F</original>
<variation>L</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037369" evidence="30">
<original>F</original>
<variation>S</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; loss of function; dbSNP:rs397514766." id="VAR_037370" evidence="28 40">
<original>T</original>
<variation>I</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO1; dbSNP:rs587777648." id="VAR_071885" evidence="41">
<original>K</original>
<variation>R</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; unknown pathological significance; reduced DNA-binding ability." id="VAR_075414" evidence="43">
<original>N</original>
<variation>Y</variation>
<location>
<position position="395"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; dbSNP:rs113994137." id="VAR_037371" evidence="30">
<original>R</original>
<variation>Q</variation>
<location>
<position position="423"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; unknown pathological significance; reduced DNA-binding ability." id="VAR_075415" evidence="43">
<original>N</original>
<variation>Y</variation>
<location>
<position position="425"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; loss of function." id="VAR_037372" evidence="28">
<original>H</original>
<variation>Y</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; loss of function." id="VAR_037373" evidence="28 30">
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1064116." id="VAR_037374" evidence="50">
<original>F</original>
<variation>Y</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037375" evidence="30">
<original>S</original>
<variation>N</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037376" evidence="30">
<original>F</original>
<variation>V</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037377" evidence="30">
<original>T</original>
<variation>I</variation>
<location>
<position position="622"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037378" evidence="30">
<original>V</original>
<variation>L</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; reduced DNA-binding ability; dbSNP:rs113994139." id="VAR_037379" evidence="30 43">
<original>V</original>
<variation>M</variation>
<location>
<position position="637"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1." id="VAR_037380" evidence="30">
<location>
<position position="644"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO1; dbSNP:rs587777649." id="VAR_071886" evidence="41">
<original>N</original>
<variation>K</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="sequence variant" description="In HIES1; reduced DNA-binding ability; dbSNP:rs193922721." id="VAR_037381" evidence="30 43">
<original>Y</original>
<variation>C</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO1; dbSNP:rs587777650." id="VAR_071887" evidence="41">
<original>K</original>
<variation>N</variation>
<location>
<position position="658"/>
</location>
</feature>
<feature type="sequence variant" description="In ADMIO1; dbSNP:rs869312892." id="VAR_071888" evidence="41">
<original>T</original>
<variation>M</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits leptin-mediated transactivation of CCND1 promoter. No effect on interaction with INPP5F." evidence="27 42">
<original>EE</original>
<variation>AA</variation>
<location>
<begin position="434"/>
<end position="435"/>
</location>
</feature>
<feature type="mutagenesis site" description="Modifies the lipid-binding pocket leading to reduction of palmitoylation levels and homodimerization." evidence="48">
<original>A</original>
<variation>V</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits palmitoylation." evidence="48">
<original>C</original>
<variation>S</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits leptin-mediated transactivation of CCND1 promoter. Inhibits Phosphorylation." evidence="27 48">
<original>Y</original>
<variation>F</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits palmitoylation." evidence="48">
<original>C</original>
<variation>S</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF84622." ref="4" evidence="56">
<original>T</original>
<variation>A</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58374." ref="1" evidence="56">
<original>Q</original>
<variation>H</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58374." ref="1" evidence="56">
<original>P</original>
<variation>S</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58374." ref="1" evidence="56">
<original>K</original>
<variation>N</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF84622." ref="4" evidence="56">
<original>E</original>
<variation>V</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58374." ref="1" evidence="56">
<original>V</original>
<variation>L</variation>
<location>
<position position="667"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58374." ref="1" evidence="56">
<original>T</original>
<variation>A</variation>
<location>
<position position="730"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="139"/>
<end position="177"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="194"/>
<end position="237"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="239"/>
<end position="251"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="261"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="297"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="321"/>
<end position="328"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="338"/>
<end position="340"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="345"/>
<end position="353"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="356"/>
<end position="358"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="359"/>
<end position="361"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="363"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="373"/>
<end position="376"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="384"/>
<end position="388"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="391"/>
<end position="393"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="398"/>
<end position="401"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="404"/>
<end position="415"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="432"/>
<end position="434"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="439"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="450"/>
<end position="457"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="461"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="467"/>
<end position="469"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="470"/>
<end position="483"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="490"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="501"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="522"/>
<end position="533"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="546"/>
<end position="549"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="557"/>
<end position="559"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="561"/>
<end position="574"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="577"/>
<end position="582"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="591"/>
<end position="600"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="605"/>
<end position="610"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="619"/>
<end position="626"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="632"/>
<end position="636"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="642"/>
<end position="645"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="650"/>
<end position="656"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="674"/>
<end position="676"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="679"/>
<end position="683"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="684"/>
<end position="686"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="3 9">
<location sequence="P40763-2">
<position position="704"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NJS"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6QHD"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P42227"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P52631"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10688651"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11773079"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12023369"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12208879"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12359225"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12763138"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12873986"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15194700"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15465816"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15467733"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15677474"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15994929"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16219639"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16568091"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344214"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17676033"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17875724"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17881745"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17956865"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18070987"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18234692"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18242580"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18599021"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19147545"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20826784"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21135090"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23084476"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23342295"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25038750"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25476455"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26293184"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26675719"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28065600"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28073828"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29924996"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31462771"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31899195"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7512451"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7701321"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9388184"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="56" type="ECO:0000305"/>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="31462771"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:11364"/>
</source>
</evidence>
<sequence length="770" mass="88068" checksum="6C00632211C8012D" modified="2004-06-07" version="2">MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSNTIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMELTSECATSPM</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

